InvestorsHub Logo
Followers 33
Posts 5265
Boards Moderated 0
Alias Born 01/23/2019

Re: postes post# 288461

Tuesday, 07/28/2020 7:18:49 PM

Tuesday, July 28, 2020 7:18:49 PM

Post# of 424595
Postes, yes it's all so crazy. Just the wording of JT's email is scattered incoherent and ambiguous. I honestly fear that if JT doesn't step aside vascepa with become just another generic, the docs will prescribe freely off label. Short story my cardio doc eye's lite up when I mentioned that Amarin lost patents. His first words were is it now a generic, then I stated that the company is appealing, his smile disappeared. My pharmacist said by law they must fill scripts with generic if available or script specifies brand name.
It's all so depressing. It would be a long term epic shareholder derivative class action, in the end no one wins. I'm assuming the worst case and Amarin loses appeal. Forget EU rights, JT will try to GIA thinking he'll retain any value that remains for a fire sale.
He must go away!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News